GTR Home > Tests > Search results - CAV3[gene]

Apply filters

Showing tests for all 800 conditions

Compare labs

More test methods
  • Hide states
More locations

GTR test search results for 859[geneid]

C Clinical test, R Research test

Showing 1 to 20 of 107 tests for 800 conditions in 35 labs

CLong QT syndrome type 9

Lab: Centogene AG - the Rare Disease Company Centogene AG Rostock, Mecklenburg-Vorpommern, Germany
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CCardiomyopathy, familial hypertrophic

Lab: Centogene AG - the Rare Disease Company Centogene AG Rostock, Mecklenburg-Vorpommern, Germany
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CArrhythmia, familial panel

Lab: Centogene AG - the Rare Disease Company Centogene AG Rostock, Mecklenburg-Vorpommern, Germany
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total targets (29)

CCaveolinopathies

Lab: (AC) Atlanta Center: Medical Neurogenetics, LLC. Atlanta, Georgia, United States
Test targets
Methods
  • C Sequence analysis of the entire coding region

CCAV3 Sequencing

Test targets
Methods
  • S Mutation scanning of the entire coding region

CLimb-Girdle Muscular Dystrophy NextGen Sequencing (NGS) Panel

Lab: PreventionGenetics Marshfield, Wisconsin, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis
Total conditions (22)
Total targets (24)

CDistal Hereditary Myopathy NextGen Sequencing (NGS) Panel

Lab: PreventionGenetics Marshfield, Wisconsin, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis
Total conditions (20)
Total targets (18)

CAutosomal Dominant Limb-Girdle Muscular Dystrophy NextGen Sequencing (NGS) Panel

Lab: PreventionGenetics Marshfield, Wisconsin, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis
Total conditions (7)
Total targets (7)

CDilated Cardiomyopathy NextGen Sequencing (NGS) panel

Lab: PreventionGenetics Marshfield, Wisconsin, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis
Total conditions (33)
Total targets (32)

CPan Cardiomyopathy Panel (51 Genes)

Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (89)
Total targets (51)

CCaveolinopathy Testing via the CAV3 Gene

Lab: PreventionGenetics Marshfield, Wisconsin, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CAutosomal Dominant Limb Girdle Muscular Dystrophy Sanger Sequencing Panel

Lab: PreventionGenetics Marshfield, Wisconsin, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (5)

CComprehensive Cardiomyopathy Panel (37 genes)

Test targets
Methods
  • X Mutation scanning of select exons
  • S Mutation scanning of the entire coding region
Total targets (37)

CStandard Long QT syndrome Stage 2

Lab: Health in Code S.L. A Coruña, Galicia, Spain
Test targets
Methods
  • C Sequence analysis of the entire coding region

CNuclearMitome Test

Lab: Transgenomic New Haven, Connecticut, United States
Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (387)
Total targets (434)

CLong QT Syndrome Panel_2013

Lab: Health in Code S.L. A Coruña, Galicia, Spain
Test targets
Methods
  • C Sequence analysis of the entire coding region
Total targets (22)

CHypertropic Cardiomyopathy Panel_2013

Lab: Health in Code S.L. A Coruña, Galicia, Spain
Test targets
Methods
  • C Sequence analysis of the entire coding region
Total targets (53)

CHypertrophic Cardiomyopathy Panel (23 genes)

Test targets
Methods
  • X Mutation scanning of select exons
  • S Mutation scanning of the entire coding region
Total targets (21)

Showing 1 to 20 of 107 tests for 800 conditions in 35 labs

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.

Write to the Help Desk